Artículos científicos
1.-Gutiérrez Rojas L, Molero Santos P, Ortuño Sánchez-Pedreño F. Perfomance in WCST in patients with schizophrenia: influence of clinical variables in manual laterality. Actas Españolas de Psiquiatría 2005; 33:173-179. (IF: 0.286)
2.- Gutiérrez-Rojas L, Gurpegui M, Ayuso-Mateos JL, Gutiérrez-Ariza JA, Ruiz-Veguilla M, Jurado D. Quality of life in bipolar disorder patients: a comparison with a general population sample. Bipolar Disorders 2008; 10:625-634. (IF: 3.959)
3.- Gutiérrez-Rojas L, Jurado D, Martínez-Ortega JM, Gurpegui M. Poor adherence to treatment associated with a high recurrence in a bipolar disorder outpatient sample. Journal of Affective Disorders 2010; 127:77-83. (IF: 3.740)
4.- Gutiérrez-Rojas L, Jurado D, Gurpegui M. Factors associated with work, social life and family life disability in bipolar disorder patients. Psychiatry Research 2011; 186:256-260. (IF: 2.524)
5.- Martínez-Ortega JM, Carretero MD, Gutiérrez-Rojas L, Díaz-Atienza F, Jurado D, Gurpegui M. Winter birth excess in schizophrenia and in non-schizophrenic psychosis: Sex and birth-cohort differences. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2011; 35:1780-1784. (IF: 3.247)
6.- Martínez-Ortega JM, Diaz-Atienza F, Gutiérrez-Rojas L, Jurado D, Gurpegui M. Cofounding by indication of a specific antipsychotic and the increase of body mass índex among children and adolescents. European Child & Adolescent Psychiatry 2011; 20:597-598. (IF: 2.821)
7.- Gurpegui M, Martínez-Ortega JM, Gutiérrez-Rojas L, Rivero J, Rojas C, Jurado D. Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sample. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2012; 37:169-175. (IF: 3.552)
8.- Martínez-Ortega JM, Gutiérrez-Rojas L, Jurado D, Higueras A, Diaz FJ, Gurpegui M. Factors associated with frequent psychiatric admissions in a general hospital in Spain. International Journal of Social Psychiatry 2012; 58:532-535. (IF: 1.147)
9.- Martínez-Ortega JM, Jurado D, Gutiérrez-Rojas L, Molero P, Ramos MA, Gurpegui M. Stability of sex differences by diagnosis in psychiatric hospitalizations. Psychiatry Research 2012; 198:161-163. (IF: 2.524)
10.- Martínez-Ortega JM, Funes-Godoy S, Díaz-Atienza F, Gutiérrez-Rojas L, Pérez-Costillas L, Gurpegui M. Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review. European Child & Adolescent Psychiatry 2013: 22:457-79. (IF: 3.339)
11.- Martínez-Ortega JM, Goldstein BI, Gutiérrez-Rojas L, Sala R, Wang S, Blanco C. Temporal sequencing of nicotine dependence and bipolar disorder in the national epidemiologic survey on alcohol and related conditions (NESARC). Journal of Psychiatric Research 2013; 47: 858-864. (IF: 3.957)
12.- Gutiérrez-Rojas L, Martínez-Ortega JM, Rodríguez-Martín FD. La sobrecarga del cuidador en el trastorno bipolar. Anales de Psicología 2013; 29:624-632. (IF: 0.549)
13.- Pérez-Costillas L, Montes R, Martínez-Ortega JM, Carretero MD, Gutiérrez-Rojas L, Gurpegui M. Phosphate levels as possible state marker in panic disorder: a preliminary study of a feasible laboratory measure for routine clinical practice. Journal of Psychiatric Research 2013; 47:1357-1362. (IF: 3.957)
14.- Basso Abad MS, Martínez Pedrosa N, Lucas Borja P, Gutiérrez-Rojas L. Interaction between meropenem and valproid acid: presentation of a case. Psiquiatría Biológica 2013; 20:14-15. (N/A)
15.- García Jiménez J, Zubimendi Pérez S, Navarrete Páez M, Gutiérrez-Rojas L. Psychotic symptoms in Sturge Weber Syndrome. Psiquiatría Biológica 2013; 20:44-46. (N/A)
16.- Jurado D, Mendieta-Marichal Y, Martínez-Ortega JM, Agrela M, Ariza C, Gutiérrez-Rojas L, Araya R, Lewis G, Gurpegui M. World region of origin and common mental disorders among migrant women in Spain. Journal of Immigrant and Minority Health 2014; 16:1111-1120. (IF: 1.314)
17.- Gutiérrez-Rojas L, Azanza JR, Bernardo M, Rojo L, Mesa F, Martínez-Ortega JM Prevalence of Metabolic Syndrome in Spanish Patients with Schizophrenia and Overweight. The CRESSOB Study. Actas Españolas de Psiquiatría 2014; 42:9-18. (IF: 1.339)
18.- Popovic D, Benabarre A, Crespo JM, Goikolea JM, González-Pinto A, Gutiérrez-Rojas L, Montes JM, Vieta E. Risk factors for suicide in schizophrenia: systematic review and clinical recommendations. Acta Psychiatrica Scandinavica 2014, 130:418-26. (IF: 6.790)
19.- Carrillo de Albornoz Calahorro CM, Guerrero-Jiménez M, Gutiérrez-Rojas L. Post-hypoxic leukoencephalopathy after carbon monoxide poisoning: case report. Psiquiatría Biológica 2015; 22:23-6. (N/A)
20.- Álvarez Ruiz EM, Gutiérrez-Rojas L. Comorbidity of bipolar disorder and eating disorders. Revista Española de Psiquiatría y Salud Mental 2015; 8:232-241. (IF: 2.227)
21.- Fontalva-Navas A, Gutiérrez-Rojas L, Arrebola JP, Pena-Andreu JM. Trends in personality disorder diagnosis in hospitalized patients: analysis of a ten-year time series. Open Journal of Psychiatry 2015; 18:3. (N/A)
22.- Guerrero-Jiménez M, Carrillo de Albornoz CM, Gutiérrez-Rojas L. Charles Bonnet syndrome or organical hallucination: A case report Psiquiatría Biológica 2015; 22:50-52. (N/A).
23.- Gutiérrez-Rojas L, Pulido S, Azanza JR, Bernardo M, Rojo L, Mesa FJ, Martínez-Ortega JM. Risk factor assessment and counselling for 12 months reduces metabolic and cardiovascular risk in overweight or obese patients with schizophrenia spectrum disorders: The CRESSOB study. Actas Españolas de Psiquiatría 2016; 44:20-29. (IF: 1.339)
24.- Fagiolini A, Alfonsi E, Cenci M, Angela Cusano A, Di Lella M, Farinella F, Ferraiuolo F, Fraguas D, Loparco N, Gutierrez-Rojas L, Mignone ML, Pataracchia G, Pillai G, Russo F, Sanchez-Gistau V, Spinogatti F, Toscano M, Villari V, De Filippis S. Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatrists. Expert Opinion on Drug Safety 2016, 15:449-455. (IF: 3.439)
25.- Pacchiarotti I, León-Caballero J, Murru A, Verdolini N, Furio MA, Pancheri C, Valentí M, Samalin L, Solé E, González-Pinto A, Montes JM, Benabarre A, Crespo JM; de Dios C, Goikolea JM, Gutierrez-Rojas L, Carvalho AF, Vieta E. Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorder. European Neuropsychopharmachology 2016, 26:1562-1578. (IF: 4.239)
26.- Jurado D, Alarcón RD, Martínez-Ortega JM, Mendieta-Marichal Y, Gutiérrez-Rojas L, Gurpegui M. Factors associated with psychological distress including common mental disorders in migrant populations across the world. Revista Española de Psiquiatría y Salud Mental 2017; 10:45-58. (IF: 2.227).
27.- Carrillo de Albornoz CM, Guerrero-Jiménez M, Gutiérrez-Rojas L. Mielinólisis central pontina inducida por antipsicóticos en un sujeto con hiperplasia central congénita. Revista de neurología 2017; 64:235-236. (IF: 0.601)
28.- López-Díaz A, Fernández-González JL, Luján-Jiménez JE, Galiano-Rus S, Gutiérrez-Rojas L. Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain. Therapeutics advances in psychopharmacology 2017, 7:137-140. (IF: 3.000)
29.- Martínez-Ortega JM, Franco S, Rodríguez-Fernández JM, Gutiérrez-Rojas L, Wang S, Gurpegui M. Temporal sequencing of nicotine dependence and major depressive disorder: a US National study. Psychiatry Research 2017, 250:264-269. (IF: 2.223)
30.- Calvo-Rivera MP, Porras A, Trigo-Rodríguez M, Martínez-Ortega JM, Gutiérrez-Rojas L. Psychosis management in patients with HIV: case report. Actas Españolas de Psiquiatría 2017, 45:71-78. (IF: 0.878)
31.- García-Jiménez J, Álvarez-Fernández M, Aguado-Bailón L, Gutiérrez-Rojas L. Epidemiological and clinical variables related with the Predominant Polarity on Bipolar Disorder: A systematic review. Revista Española de Psiquiatría y Salud Mental 2019; 12:52-62. (IF: 2.630).
32.- Sarramea F, Jaén-Moreno MJ, Balanzá-Martínez V, Osuna MI, Alcalá JA, Montiel FJ, Gómez C, Sánchez MD, Rico AB, Redondo-Écija J, Gil S, Valdivia F, Caballero-Villarraso J, Gutiérrez-Rojas L. Setting the stage to quit smoking in Bipolar Disorder patients: brief advice in clinical practice. Adicciones 2019; 31:136-146. (IF: 2.979).
33.- Molero P, Ramos-Quiroga JA, Martin-Santos R, Calvo-Sánchez E, Gutiérrez-Rojas L, Meana JJ. Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review. CNS Drugs 2018;32:411-420. (IF: 4.192).
34.- Carrillo de Albornoz Calahorro CM, López-Delgado D, Gutiérrez-Rojas L. Morgellons disease treatment with quetiapine. Medicina Clinica (Barc) 2019; 153:118-120. (IF: 1.725).
35.- Arango C, Baeza I, Bernardo M, Cañas F, de Dios C, Díaz-Marsa M, García-Portilla MP, Gutiérrez-Rojas L, Olivares JM, Rico-Villademoros F, Rodríguez-Jiménez R, Sánchez-Morla EM, Segarra R, Crespo-Facorro B. Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain. Revista Española de Psiquiatría y Salud Mental 2019; 12:92-105. (IF: 2.630).
36.- Carrillo de Albornoz CM, Guerrero-Jiménez M, Gutiérrez-Rojas L. Sleep-related eating disorder caused by zolpidem: case report and review of the literature. Dusuem Adam The Journal of Psychiatry and Neurological Science 2018; 31:195-200. (IF: 0.060)
37.- Sarramea F, Jaén-Moreno MJ, Feu N, Redondo-Écija J, Balanzá-Martínez V, Gutiérrez-Rojas L, García-Portilla MP. Prepare the smoking cessation in severe mental illness: Early diagnosis and prevention opportunities. Revista Española de Psiquiatría y Salud Mental 2019; 12:133-134. (IF: 2.630).
38.- Velázquez-Navarrete E, Gutiérrez-Rojas L. Competencia para decidir y tipo de internamiento en conducta suicida. De la teoría a la práctica. Revista Española de Medicina Legal 2019; 45:136-142. (N/A).
39.- Benabarre A, Campos JA, Russo F, Cerveri G, Prestia D, González S, Pérez-Sendino A, Gutiérrez-Rojas L. Aripiprazole treatment in clinical practice: expert panel consensus. Psiquiatría Biológica 2018; 25:89-95. (N/A).
40.- Ramón-Jarne FJ, Jurado D, Jiménez-Fernández S, Gutiérrez-Rojas L, Martínez-Ortega JM, Gurpegui M. Disordered eating behaviors among Christian and Muslim adolescents in Ceuta, a multicultural town. Psychiatry Research 2019; 272:182-189. (IF: 2.118)
41.- Jaén-Moreno MJ, Feu N, Redondo-Écija J, Montiel FJ, Gómez C, del Pozo GI, Alcalá JA, Gutiérrez-Rojas L, Balanzá-Martinez V, Chauca GM, Carrión L, Osuna MI, Sánchez MD, Caro I, Ayora M, Valdivia F, López MS, Poyato JM, Sarramea F. Smoking cessation opportunities in Severe Mental Illness. Tobacco Intensive Motivational and Estimate Risk (TIMER): study protocol for a randomized controlled trial. Trials 2019; 20:47. (IF: 1.883)
42.- Jiménez E, Bonnín CDM, Solé B, Sánchez-Moreno J, Reinares M, Torrent C, Torres I, Salagre E, Varo C, Ruiz V, Giménez A, Benabarre A, Gutiérrez-Rojas L, Cervilla J, Sáiz PA, Bobes J, Amann BL, Martínez-Arán A, Vieta E. Spanish validation of the Barcelona TEMPS-A questionnaire in bipolar patients and general population. Journal of Affective Disorders 2019; 249:199-207. (IF: 3.892)
43.- Sarramea F, Jaén-Moreno MJ, Gutiérrez-Rojas L, Balanzá-Martínez V, García-Alvarez L, Saiz Martínez PA, Garcia-Portilla MP, Guler I, Bobes J. Readiness predicts efficacy of reduction among smokers with SMI. European Adicction Research 2019; 4:1-7. (IF: 2.269)
44.- Guerrero-Jimenez M, Carrillo de Albornoz Calahorro CM, Gutiérrez-Rojas L. Wilson disease and psychiatric symptoms: A brief case report. General Psychiatry 2019; 32:e100066. (IF: 0.140)
45.- Carrillo de Albornoz Calahorro CM, Navarrete MI, Guerrero-Jimenez M, Gutiérrez-Rojas L. Successful treatment of psychosis induced by interferon alfa and ribavirin with paliperidone: the first case reported. General Psychiatry 2019; 32:e100075. (IF: 0.480)
46.- Martínez-Ortega JM, Nogueras P, Muñoz-Negro JE, Gutiérrez-Rojas L, González-Domenech P, Gurpegui M. Quality of life, anxiety and depressive symptoms in patients with psoriasis: a case-control study. Journal of Psychosomatic Research 2019; 124:109780. (IF: 2.860).
47.- González Domenech PJ, Díaz Atienza F, García Pablos C, Serrano Nieto S, Herreros Rodríguez O, Gutiérrez-Rojas L, Martínez-Ortega JM. Influence of a gluten-free, casein-free diet on behavioral disturbances in children and adolescents diagnosed with autism spectrum disorder: a 3-month follow-up pilot study. Journal of Mental Health Research in Intellectual Disabilities 2019; 12:256-272. (IF: 4.291).
48.- Andrade-González N, Hernández-Gómez A, Álvarez-Sesmero S, Gutiérrez-Rojas L, Vieta E, Reinares M, Lahera G. The influence of the working alliance on the treatment and outcomes of patients with bipolar disorder: a systematic review. Journal of Affective Disorders 2020; 260:263-271. (IF: 4.839)
49.- Cano-Ruiz P, Sanmartin-Salinas P, Gómez-Peinado A, Calero-Mora C, Gutiérrez-Rojas L. Diagnostic stability in bipolar disorder: a systematic review. Actas Españolas de Psiquiatría 2020, 48:28-36. (IF: 1.196)
50.- Gonzalez-Pinto A, Balanzá-Martinez V, Benabarre A, Gutiérrez-Rojas L, Montes JM, de Dios C, Pérez Sola V, Montejo AL, Giménez Palomo A, Crespo JM. Expert consensus on information sheet proposals for patients under treatment with Lithium. Revista Española de Psiquiatría y Salud Mental 2019; S1888-9891(19)30102-8. (IF: 2.630).
51.- Gutiérrez-Rojas L, Martínez-Ortega JM, Pérez-Costillas L, Jiménez-Fernández S, Carretero MD, Gurpegui M. Illness insight and medication adherence among patients with bipolar disorder. The Journal of Nervous and Mental Disease 2020; 208:481-487. (IF: 2.254).
52.- González Domenech PJ, Díaz F, García C, Fernandez Soto ML, Martínez-Ortega JM, Gutiérrez-Rojas L. Influence of a combined gluten-free and casein-free diet on behavior disorders in children and adolescents diagnosed with autism spectrum disorder: a 12-month follow-up clinical trial. Journal of Autism and Developmental Disorders 2020, 50:935-948. (IF: 4.291).
53.- Porras-Segovia A, Díaz-Oliván I, Gutiérrez-Rojas L, Dunne H, Moreno M, Baca-García E. Apps for depression: Are they ready to work? Current Psychiatry Reports 2020; 22:11. (IF: 5.285).
54.- Gutiérrez-Rojas L, Porras-Segovia A, Dunne H, Andrade-González N, Cervilla-Ballesteros J. Prevalence and correlates of Major Depressive Disorder: a systematic review. Brazilian Journal of Psychiatry 2020; 42:657-672. (IF: 3.016).
55.- Escudero MAG, Gutiérrez-Rojas L, Lahera G. Second generation antipsychotics monotherapy as maintenance treatment for bipolar disorder: a systematic review of long-term studies. Psychiatry Quarterly 2020; 91:1047-1060. (IF: 2.832).
56.- Villagrasa B, García-Jiménez J, Bodoano I, Gutiérrez-Rojas L. Obesity and depression: its prevalence and influence as a prognostic factor. A systematic review. Psychiatry Investigation 2020; 17:715-724. (IF: 2.505).
57.- Carrillo de Albornoz Calahorro CM, Guerrero-Jimenez M, Gutiérrez-Rojas L. Peduncular hallucination status secondary to thalamic stroke: brief case report and review of the literature. Acta Scientific Neurology 2020; 3:9. (N/A).
58.- Jiménez-Muñoz L, Gutiérrez-Rojas L, Porras-Segovia A, Courtet P, Baca-García E. Mobile applications for the management of chronic physical conditions: A systematic review. Internal Medicine Journal 2022; 52:21-29. (IF: 2.048)
59.- García-Jimenez J, Gutiérrez-Rojas L, Jiménez-Fernández S, González-Domenech P, Carretero MD, Gurpegui M. Features associated with depressive predominant polarity and late illness onset in patients with bipolar disorder. Frontiers in Psychiatry 2020; 11:584501 (IF: 4.157)
60.- Navarrete-Páez MI, Calvo Rivera P, Gutiérrez-Rojas L. Paraganglioma neuroendocrine tumor and psychiatric implications. A case report. Psiquiatría Biológica 2021; 28:14-17. (N/A).
61.- Porras-Segovia A, Guerrero-Jimenez M, Carrillo de Albornoz Calahorro CM, Gutiérrez-Rojas L. Psychosis and Dandy-Walker syndrome: a case report and review of the literature. General Psychiatry 2021; ;34:e100254. (IP: 0.480).
62.- Jaen-Moreno MJ, Feu N, del Pozo GI, Gómez C, Carrión L, Chauca Gm, Guler I, Montiel FJ, Sánchez MD, Alcalá JÁ, Gutiérrez-Rojas L, Molina V, Bobes J, Balanzá-Martínez V, Ruiz-Rulla C, Sarramea F. Chronic Obstructive Pulmonary Disease in severe mental illness: a timely diagnosis to advance the process of quitting smoking. European Psychiatry 2021; 26:1-26. (IF: 5.361)
63.- Bodoano Sánchez I, Fernández-Pérez MD, Molera Manzano D, Gutiérrez-Rojas L, Romero-Fábrega JC. Visual hallucinations in a patient with Moyamoya’s disease. A case report. Cognitive and behavioral neurology 2021; 34:63-69. (IF: 1.600)
64.- Jiménez-Fernández S, Gurpegui M, Garrote-Rojas D, Gutiérrez-Rojas L, Carretero MD, Correll CU. Oxidative stress parameters and antioxidants in patients with bipolar disorder: Results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls. Bipolar Disorders 2021; 23:117–129. (IF: 6.744)
65.- Girela Serrano B, Guerrero-Jimenez M, Spiers A, Gutiérrez-Rojas L. Obesity and overweight among children and adolescents with bipolar disorder from the general population: a review of the scientific literature. Early Intervention in Psychiatry 2022; 16:113-125. (IF: 2.732)
66.- Valdés-Florido MJ, López-Díaz A, Palermo-Zeballos FJ, Garrido-Torres N, Álvarez-Gil P, Martínez-Molina I, Martín-Gil VE, Ruiz-Ruiz E, Mota-Molina M, Algarín-Moriana MP, Guzmán-del Castillo AH, Ruiz-Arcos A, Gómez-Coronado R, Galiano-Rus S, Rosa-Ruiz A, Prados-Ojeda JL, Gutierrez-Rojas L, Crespo-Facorro B, Ruiz-Veguilla M. Clinical characterization of brief psychotic disorders triggered by the COVID-19 pandemic: a multicenter observational study. European Archives of Psychiatry and Clinical Neuroscience 2022; 272:5-15. (IF: 5.276)
67.- Benavente-Fernández A, Gutierrez-Rojas L, Torres-Parejo Ú, Fernández Ontiveros S, Vinuesa García D, González-Domenech P, Laínez Ramos-Bossini AJ. Psychological impact and risk of suicide in hospitalised COVID-19 patients, during the initial stage of the pandemic: a cross-sectional study. Journal of Patient Safety 2022; 18:499-506. (IF: 2.844)
68.- Gutierrez-Rojas L, González-Domenech PJ, Junquera G, Halverson TF, Lahera G. Functioning and happiness in people with schizophrenia: Analyzing the role of cognitive impairment. International Journal of Environmental and Public Health 2021; 18:7706. (IF: 3.390)
69.- De Diego-Adeliño J, Crespo JM, Mora F, Neyra A, Iborra P, Gutiérrez-Rojas L, Salonia SF. Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review. Expert Opinion on Drug Safety 2021; 1-18. (IF: 4.250)
70.- Linares-Gonzalez L, Lozano-Lozano I, Gutiérrez-Rojas L, Ruiz-Villaverde R, Lozano-Lozano M. Sexual dysfunction in a cohort of patients with moderate-severe atopic dermatitis. Influence of Dupilumab treatment. International Journal of Dermatology 2022, 61:607-610. (IF: 2.736)
71.- de la Fuente-Tomás L, Arranz B, Sierra P, Sánchez-Autet M, García-Blanco A, Gutiérrez-Rojas L, Balanzá-Martínez V, Vidal-Rubio SL., Vieta E, Jiménez E, Hernández C, Arrojo M, Gómez-Trigo J, Zapico-Merayo Y, Pelayo-Terán JM, Pérez-Solà V, Mur E, Cardoner N, González-Pinto A, Zorrilla I, Ruiz-Veguilla M, Catalán-Barragán R, Safont G, Martínez-Cao C, Sáiz PA, Bobes J, García-Portilla MP. Spanish validation of the Empirically Developed Clinical Staging Model (EmDe-5) for patients with bipolar disorder. Revista Española de Psiquiatría y Salud Mental 2021; in press. (IF: 6.795).
72.- de Jaime Ruiz P, García-Fogeda Romero JL, Gutiérrez-Rojas L. Catatonia and mutism: neurotic, psychotic or organic disorder? Case Reports in Psychiatry 2021; 2021:5936673. (IF: 0.690)
73.- Gonzalez-Domenech P, Romero-Béjar JL, Gutiérrez-Rojas L, Jimenez-Fernandez S, Diaz-Atienza F. Behavioural difficulties in children and adolescents with mental disorders under extreme situations. Journal of Clinical Medicine 2021; 10:4876. (IF: 4.242).
74.- Guerrero-Jiménez M, Carrillo de Albornoz Calahorro CM, Girela Serrano B, Bodoano I, Gutiérrez-Rojas L. Post Psychotic Depression, an updated review of the term and clinical implications. Psychopathology 2022; 55(2):82-92. (IF: 1.944).
75.- Linares-Gonzalez L, Lozano-Lozano I, Gutierrez-Rojas L, Mario Lozano-Lozano, Rodenas-Herranz T, Ruiz-Villaverde R. Sexual dysfunction and atopic dermatitis: A systematic review. Life 2021; 11:1314. (IF: 3.187)
76.- Fuentes A, de Salazar A, Aguilera A, Téllez F, Cervilla J, González-Domenech PJ, Gutiérrez-Rojas L, García F. Hepatitis C virus screening and linkage to care in mental health units: an opportunity for HCV elimination. Actas Españolas de Psiquiatría 2022; 50:120-121. (IF: 1.196)
77.- Moreno M, Gutiérrez-Rojas L, Porras-Segovia A. Implicit cognition tests for the assessment of suicide risk: A systematic review. Current Psychiatry Reports 2022;1-19. (IF: 5.285)
78.- Jiménez-Muñoz L, Peñuelas-Calvo I, Díaz-Oliván I, Gutiérrez-Rojas L, Baca-García E, Porras-Segovia A. Suicide prevention in your pocket: A systematic review of ecological momentary interventions for the management of suicidal thoughts and behaviors. Harvard Review of Psychiatry 2022; 30:85-99. (IF: 3.732)
79.- Piñar Morales R, Carrasco García M, Gutiérrez-Rojas L, Barrero Hernández FJ. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome after discontinuation of fingolimod. Case Reports in Neurology 2022; 14:38-43. (IF: 0.190).
80.- Calvo Rivera MP, Navarrete Páez MI, Bodoano I, Gutiérrez-Rojas L. Comorbidity between Anorexia Nervosa and Depressive Disorder: a narrative review. Psychiatry Investigation 2022; 19:155-163. (IF: 2.505).
81.- García Vázquez P, Serrano García A, Vilella Martín C, Franch Pato CM, Moreno M, Gutiérrez-Rojas L. Gender implications in the seasonal pattern of bipolar disorder. A systematic review. Minerva Psychiatry 2022; 63:69-78. (IF: 0.190)
82.- de Anta L, Alvarez-Mon MA, Ortega MA, Salazar C, Donat-Vargas C, Santoma-Vilaclara J, Martin-Martinez M, Lahera G, Rodriguez-Jimenez R, Gutiérrez-Rojas L, Javier Quintero J, Álvarez-Mon M. Areas of interest and social consideration of antidepressants on Twitter: A machine learning study. Journal of Personalized Medicine 2022;12:155. (IF: 4.945).
83.- González-Rodríguez A, Monreal JA, Porras-Segovia A, Cervilla JA, Gutiérrez-Rojas L. Psychometric instruments for the assessment of depressive symptoms in patients with delusional disorder: A systematic review. Psychiatry Research 2022; 310:114435. (IF: 3.222).
84.- Gutiérrez‐Rojas L, Sánchez-Alonso S, García Dorado M, López Rengel PM. Impact of 3-monthly long-acting injectable paliperidone palmitate in Schizophrenia: A retrospective, real-world analysis of population-based health records study in Spain. CNS Drugs 2022; 36:517-527. (IF: 5.754).
85.- Alvarez-Mon MA, Ortega MA, García-Montero C, Fraile-Martinez O, Lahera G, Monserrat J, Gomez-Lahoz AN, Molero P, Gutierrez-Rojas L, Roberto Rodriguez-Jimenez R, Quintero J, Alvarez-Mon M. Differential Malondialdehyde (MDA) detection in plasma samples of patients with Major depressive disorder (MDD): A potencial biomarker. Journal of International Medical Research 2022;50:3000605221094995. (IF: 1.671).
86.- de las Cuevas C, Gutiérrez-Rojas L, Alvarez-Mon MA, Andreu-Bernabeu A, Capitán L, Gómez JC, Grande I, Hidalgo-Mazzei D, Mateos R, Moreno-Gea P, De Vicente-Muñoz T, Ferre F. Evaluating the Effect of a Telepsychiatry Educational Program on the Awareness, Knowledge, Attitude and Skills of Telepsychiatry among Spanish Psychiatrists during COVID-19 Pandemic. Telemedicine and e-health 2022, in press. (IF: 3.536)
87.- Bodoano Sánchez I, Mata Agudo A, Guerrero-Jiménez M, Girela Serrano B, Álvarez Gil P, Carrillo de Albornoz Calahorro CM, Gutiérrez-Rojas L. Treatment of post-psychotic depression in first-episode psychosis. A systematic review. Nordic Journal of Psychiatry 2022, 1-9. (IF: 2.202)
88.- González-Domenech PJ, Díaz-Atienza F, Gutiérrez-Rojas L, Fernández-Soto ML, González-Domenech CM. A narrative review about Autism Spectrum Disorders and exclusion of gluten and casein from the diet. Nutrients 2022, 14:1797. (IF: 5.719)
89.- González-Blanco L, Moya-Lacasa C, Jiménez-Fernández S, Martínez-Cao C, Valtueña-García M, Dal Santo F, García-Portilla MP, Gutiérrez-Rojas L. Endocrine biomarkers related to sleep-wake cycle and sleep disturbances in patients with bipolar disorder: A systematic review. The European Journal of Psychiatry 2022; in press (IF: 0.673)
90.- Gutiérrez-Rojas L, de la Gándara Martín JJ, Garcia Buey L, Uriz Otano JI, Mena A, Roncero C. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: results of a literature review. Gastroenterología y Hepatología 2022:S0210-5705(22)00164-9. (IF: 2.102)
91.- Jiménez-Fernández S, Gurpegui M, de Leon J, Gutiérrez-Rojas L. Clozapine for the treatment of pediatric encephalopathy associated with nonketotic hyperglycinemia. Revista de Psiquiatría y Salud Mental 2022; in press. (IF: 3.318)
92.- Alcalá Partera J, Fontalba-Navas A, Company-Morales M, Romero-Guillena S, Gutiérrez-Higueras T, Gutierrez-Rojas L. Facilitators and barriers of medication adherence based on patients’ beliefs about Bipolar Disorder: A qualitative study. International Journal of Environmental and Public Health 2022;19:7633. (IF: 3.390)
93.- Conejo J, Sanz-Giancola A, Álvarez-Mon MA, Ortega MA, Gutiérrez-Rojas L, Lahera G. Postpartum relapse in patients with bipolar disorder. Journal of Clinical Medicine 2022;11:3979. (IF: 4.964)
94.- Gutiérrez-Rojas L, Alvarez-Mon MA, Andreu-Bernabeu A, Capitán L, de las Cuevas C, Gómez JC, Grande I, Hidalgo-Mazzei D, Mateos R, Moreno-Gea P, De Vicente-Muñoz T, Ferre F. Telepsychiatry: the future is already present. Revista Psiquiatría y Salud Mental 2022; in press. (IF: 6.795)
95.- Jiménez-Fernández S, Gurpegui M, Garrote-Rojas D, Gutiérrez-Rojas L, Carretero MD, Correll CU. Oxidative stress parameters and antioxidants in adults with unipolar or bipolar depression versus healthy controls: systematic review and meta-analysis. Journal of Affective Disorders 2022;314:211-221. (IF: 6.533)
96.- Ortega MA, Fraile-Martinez O, García-Montero C, Alvarez-Mon MA, Lahera G, Monserrat J, Llavero-Valero M, Gutiérrez-Rojas L, Molina-Ruiz RM, Rodriguez-Jimenez R, Quintero J, Álvarez-Mon M. Biological Role of Nutrients, Food and Dietary Patterns in the Prevention and Clinical Management of Major Depressive Disorder. Nutrients 2022;14(:3099. (IF: 6.706)
97.- Cruz S, Gutiérrez-Rojas L, González-Domenech P, Díaz-Atienza F, Martínez-Ortega JM, Sara Jiménez-Fernández S. Deep Brain Stimulation in Obsessive-Compulsive disorder: results from meta-analysis. Psychiatry Research 2022, in press. (IF: 11.225)
98.- Porras-Segovia A, Peñuelas-Calvo I, Nobile B, Gutiérrez-Rojas L. Editorial: Interventions based on new technologies for the management of mood disorders. Frontiers in Psychiatry 2022, in press. (IF: 5.435)
99.- Villanueva V, Artal J, Cabeza-Alvarez CI, Campos D, Castillo A, Flórez G, Franco-Martin M, García-Portilla MP, Giráldez BG, Gotor F, Gutiérrez-Rojas L, Molins Albanell A, Paniagua G, Pintor L, Poza JJ, Rubio-Granero T, Toledo M, Tortosa-Conesa D, Rodríguez-Uranga J, Bobes J. Recommendations for the management of depression in adults with epilepsy: an expert consensus. Neurology and Therapy 2023, in press. (IF: 4.446)
100.- Margarita Guerrero-Jiménez M, Ruiz M, Gutierrez-Rojas L, Jiménez Muñoz L, Baca-García E, Porras-Segovia A. Use of new technologies for the promotion of physical activity in patients with mental illness: a systematic review. World Journal of Psychiatry 2023, in press. (IF: 3.500)
